Summary: In a prespecified effect-modifier analysis of the MIND diet trial, which was overall negative for cognition, BMI was the only significant modifier: a cognitive benefit appeared only in older adults with BMI 35 or above, not in those with lower BMI.
PICO Summary
| Element | Detail |
|---|---|
| Population | 604 community-dwelling adults aged 65–85 with overweight or obesity (mean BMI 33.9); analysis of the MIND diet RCT, USA. |
| Intervention | MIND diet (leafy greens, berries, nuts, fish, olive oil; limited red meat, butter, cheese, sweets, fried food). |
| Comparison | Calorie- and contact-matched control diet. |
| Outcome | BMI was the only significant effect modifier (p=0.009). Only among participants with BMI ≥35 (n=213) did the MIND diet improve global cognition, by 0.040 standardized units per year (p=0.018). There was no significant effect in those with lower BMI, and the parent trial was overall null. |
Expert Commentary
This analysis must be read against the inconvenient backdrop that the main MIND diet trial did not show a cognitive benefit overall, and that fact should anchor interpretation. What this paper adds is a single significant effect modifier, BMI, with the benefit confined to participants with class II or higher obesity. There is a plausible mechanistic narrative, that severe obesity carries more inflammation, insulin resistance, and cerebrovascular burden, giving an anti-inflammatory dietary pattern more to act on, but plausibility is not proof. The honest framing, which the authors themselves adopt, is that a subgroup finding from an overall-null trial is hypothesis-generating rather than confirmatory: the trial was not powered for subgroups, multiple characteristics were tested, and the calorie-matched control diet was itself reasonably healthy, narrowing any contrast. Can I use this with my patients? Cautiously and without overpromising. I would not present the MIND diet as proven to protect cognition, since the primary result was negative, but given that it overlaps heavily with heart-healthy and diabetes-prevention eating, I am comfortable recommending it for its broad cardiometabolic merits, and this signal is at most a gentle reason to emphasise it in patients with severe obesity while awaiting confirmatory trials.
References
Halloway S, Aggarwal NT, Arfanakis K, Sacks FM, Barnes LL, Dhana K. Effect modifiers of the MIND diet for cognition in older adults: the MIND diet trial. Alzheimers Dement. 2025;21(10):e70731. doi:10.1002/alz.70731